IMMVIRX
Who is IMMVIRX?
ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect. The company is developing a bio-selected RNA virus to induce tumour inflammation and achieve immune cell infiltration via the RIG...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2019 (7 years)
Address:
HMRI BUILDING, 2 KOOKABURRA CIRCUIT; NEW LAMBTON HEIGHTS, NSW 2305, AU
Employees by Department
- IT / Product (1)
- Operations (1)
- The Rest (10)
- Total (12)
Key Decision Makers
Cameron Oppy
Senior Analyst
Alison Wylie
Senior Quality Assurance Associate
Cecilia Russell
Senior Quality Associate
Szun Tay
Senior Research Associate
Employees by Seniority
C-level
2employees
Senior
4employees
Non-managers
4employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has IMMVIRX been operating for?
- What is the funding status of IMMVIRX?
- Where is IMMVIRX's headquarter?
- What IMMVIRX's spending power?
- Does IMMVIRX have a presence in the domain it operates in?